Biotechnology in the United Kingdom

March 2025 | 47 pages | ID: B5AA606CD154EN
MarketLine

Abstracts

Biotechnology in the United Kingdom

Summary

Biotechnology in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

• Biotechnology market encompasses a broad range of technologies, products, and services that utilize biological systems, organisms, or derivatives to develop or modify processes or products for specific applications. Market value refers to the revenue generated from product sales, licensing fees, royalties, and research funding.
• The UK biotechnology market recorded revenues of $120.0 billion in 2024, representing a compound annual growth rate (CAGR) of 3.1% between 2019 and 2024.
• The medical/healthcare segment accounted for the market's largest proportion in 2024, with total revenues of $84.5 billion, equivalent to 70.4% of the market's overall value.
• The UK biotechnology market is experiencing unprecedented growth, fueled by a surge in equity financing and venture capital investments.

Scope

• Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the United Kingdom
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in the United Kingdom
• Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the United Kingdom biotechnology market with five year forecasts

Reasons to Buy

• What was the size of the United Kingdom biotechnology market by value in 2024?
• What will be the size of the United Kingdom biotechnology market in 2029?
• What factors are affecting the strength of competition in the United Kingdom biotechnology market?
• How has the market performed over the last five years?
• What are the main segments that make up the United Kingdom's biotechnology market?

Contents

1 EXECUTIVE SUMMARY

1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape

2 MARKET OVERVIEW

2.1. Market definition
2.2. Market analysis

3 MARKET DATA

3.1. Market value

4 MARKET SEGMENTATION

4.1. Category segmentation
4.2. Geography segmentation

5 MARKET OUTLOOK

5.1. Market value forecast

6 FIVE FORCES ANALYSIS

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 COMPETITIVE LANDSCAPE

7.1. Who are the key players?
7.2. What strategies do the key players follow?
7.3. What have been the most recent market developments?

8 COMPANY PROFILES

8.1. AstraZeneca Plc
8.2. GSK plc
8.3. Oxford Nanopore Technologies Plc
8.4. Immunocore Holdings Plc

9 MACROECONOMIC INDICATORS

9.1. Country data

10 APPENDIX

10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine